Bristol Myers Squibb (BMY): analysis and statistics
Return, volatility, Sharpe ratio and risk for Bristol Myers Squibb, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $64.86 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +6.33% |
| Total return over period | +20.12% |
| Annualized volatility | 27.53% |
| Sharpe ratio | 0.10 |
| Sortino ratio | 0.14 |
| Max drawdown | -34.11% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.76% |
| Correlation with the S&P 500 | 0.15 |
| Period range | $35.96 – $64.86 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Bristol Myers Squibb (BMY) has posted an annualized return of +6.33% with annual volatility of 27.53%, a Sharpe ratio of 0.10. Its worst stretch (max drawdown from a peak) was -34.11%. Its correlation with the S&P 500 is 0.15, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how BMY would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with BMY →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio